P34913 (HYES_HUMAN) Homo sapiens (Human)

Bifunctional epoxide hydrolase 2 UniProtKBInterProSTRINGInteractive Modelling

555 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3)

Available Structures

114 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of human soluble epoxide hydrolase complexed with N-cycloheptyl-1-(mesitylsulfony…homo-2-mer1-548
PO4;MG;I23;
Assess
Crystal structure of human soluble epoxide hydrolase complexed with fulvestranthomo-2-mer1-548
PO4;MG;FVS;
Assess
Crystal structure of human soluble epoxide hydrolase complexed with 1-(1-isobutyrylpiperidin-4-yl)-…homo-2-mer1-548
PO4;MG;2RU;
Assess
Ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-548
PEG;SO4;DMS;JF6;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-548
DMS;GVG;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-548
SO4;GOL;PEG;DMS;6NF;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-548
12×DMS;GOL;4VY;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-548
SO4;KJU;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-548
SO4;DMS;PEG;9XZ;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-548
SO4;DMS;II6;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-548
SO4;DMS;KWB;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-548
SO4;DMS;XM0;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-548
DMS;BSU;
Assess
Human soluble epoxide hydrolase 4-(3-cyclohexyluriedo)-butyric acid complexhomo-2-mer2-548
MG;PO4;15P;NC4;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-548
OE1;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-548
DMS;SZC;
Assess
Human soluble Epoxide Hydrolase- N-cyclohexyl-N'-(4-iodophenyl)urea complexhomo-2-mer2-548
MG;PO4;P6G;CIU;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-548
SO4;DMS;6N6;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-548
SO4;5DQ;
Assess
Human soluble epoxide hydrolase 4-(3-cyclohexyluriedo)-heptanoic acid complexhomo-2-mer2-548
MG;PO4;NC7;
Assess
Human soluble epoxide hydrolase 4-(3-cyclohexyluriedo)-hexanoic acid complexhomo-2-mer2-548
MG;PO4;NC6;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-548
SO4;GZP;
Assess
Crystal structure of human soluble epoxide hydrolase complexed with 1-(1-propanoylpiperidin-4-yl)-3…homo-2-mer1-547
PO4;MG;2RV;
Assess
Crystal structure of human soluble epoxide hydrolase complexed with trans-4-[4-(3-trifluoromethoxyp…homo-2-mer2-548
PO4;MG;BXV;CL;
Assess
Human soluble epoxide hydrolase 4-(3-cyclohexyluriedo)-ethanoic acid complexhomo-2-mer2-548
MG;PO4;NC3;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;DMS;PEG;KUF;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;6TZ;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;GOL;K78;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;PEG;Q3B;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;GOL;K2T;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4; 14×DMS;MVJ;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
HD2;DMS;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;DMS;LWS;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;PEG;TGX;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
DMS;SO4;4UA;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;1P8;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4; 10×DMS;B7H;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;GOL;ONR;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
10×DMS;SO4;5ZM;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
DMS;A0J;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;6N8;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
DMS;7GM;
Assess
Apo structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;GOL;
Assess
Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitorhomo-2-mer2-547
MG;PO4;S0G;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4; 10×DMS;6N4;
Assess
Structure of soluble epoxide hydrolase in complex with N-methyl-1-[3-(pyridin-3-yl)phenyl]methanami…homo-2-mer2-547
MG;3C5;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;GOL;PEG;QYD;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;DMS;8NY;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;DMS;6NM;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;GOL;T5J;
Assess
Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitorhomo-2-mer2-547
MG;PO4;S0B;
Assess
Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitorhomo-2-mer2-547
MG;PO4;S0A;
Assess
Structure of soluble epoxide hydrolase in complex with N-[(1-methyl-1H-pyrazol-3-yl)methyl]-2-pheny…homo-2-mer2-547
MG;49G;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;PEG;GOL;YPN;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;DMS;I5T;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;DMS;6NJ;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;GOL;6NX;
Assess
Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitorhomo-2-mer2-547
MG;PO4;S0F;
Assess
Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitorhomo-2-mer2-547
MG;PO4;S0D;
Assess
Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitorhomo-2-mer2-547
MG;PO4;S0I;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;DMS;JQN;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;GOL;PEG;AUB;
Assess
Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitorhomo-2-mer2-547
MG;PO4;S0J;
Assess
Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitorhomo-2-mer2-547
MG;PO4;S0E;
Assess
Comparison of room-temperature and cryogenic structures of soluble Epoxide Hydrolase with ligands b…homo-2-mer2-547
PEG;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
DMS;V2Z;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;DMS;DUL;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
DMS;6NZ;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
DMS;GOL;SO4;6N0;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
DMS;SO4;FCW;
Assess
Structure of soluble epoxide hydrolase in complex with 2-(2-fluorophenyl)-N-[(5-methyl-2-thienyl)me…homo-2-mer2-547
MG;49Z;
Assess
Structure of soluble epoxide hydrolase in complex with 1-[3-(trifluoromethyl)phenyl]-1H-pyrazol-4-olhomo-2-mer2-547
MG;49P;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;XQ9;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;DMS;WMR;
Assess
Structure of soluble epoxide hydrolase in complex with 1-[3-(trifluoromethyl)pyridin-2-yl]piperazinehomo-2-mer2-547
MG;49N;
Assess
Structure of soluble epoxide hydrolase in complex with (4-bromo-3-cyclopropyl-1H-pyrazol-1-yl)aceti…homo-2-mer2-547
MG;4A5;
Assess
Structure of soluble epoxide hydrolase in complex with 3-[4-(benzyloxy)phenyl]propan-1-olhomo-2-mer2-547
MG;49Q;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
DMS;SO4;R4N;
Assess
Structure of soluble epoxide hydrolase in complex with 2-(piperazin-1-yl)nicotinonitrilehomo-2-mer2-547
MG;49O;
Assess
Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitorhomo-2-mer2-547
MG;PO4;S0K;
Assess
Structure of soluble epoxide hydrolase in complex with 2-({[2-(adamantan-1-yl)ethyl]amino}methyl)ph…homo-2-mer2-547
MG;4A0;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-547
SO4;8TM;
Assess
Structure of soluble epoxide hydrolase in complex with tert-butyl 1,2,3,4-tetrahydroquinolin-3-ylca…homo-2-mer2-547
MG;49R;
Assess
Crystal structure of soluble epoxide hydrolase in complex with t-AUCBhomo-2-mer2-547
MG;PO4;AUB;
Assess
Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitorhomo-2-mer2-547
MG;PO4;S0C;
Assess
Crystal Structure of soluble epoxide Hydrolasehomo-2-mer4-548
34N;
Assess
ligand complex structure of soluble epoxide hydrolasehomo-2-mer2-546
SO4;DMS;GOL;4XH;
Assess
Crystal Structure of soluble epoxide Hydrolasehomo-2-mer4-548
33N;
Assess
Human soluble Epoxide Hydrolasehomo-2-mer4-548
P6G;
Assess
Crystal Structure of soluble epoxide Hydrolasehomo-2-mer4-548
24D;
Assess
Soluble Epoxide Hydrolase in complex with pyrazole antagonisthomo-2-mer4-548
MZL;
Assess
Crystal structure of hydrolase domain of human soluble epoxide hydrolase complexed with a benzoxazo…homo-2-mer226-548
ZYI;
Assess
Soluble epoxide hydrolase in complex with talinololhomo-2-mer229-547
MG;G3Q;
Assess
Soluble epoxide hydrolase in complex with 3-((R)-3-(1-hydroxyureido)but-1-yn-1-yl)-N-((S)-3-phenyl-…homo-2-mer229-547
OWW;
Assess
Soluble epoxide hydrolase in complex with FL217homo-2-mer229-547
5IV;
Assess
Soluble epoxide hydrolase in complex with 1-(4-((4-(tert-butyl)morpholin-2-yl)methoxy)phenyl)-3-cyc…homo-2-mer229-547
MG;G3T;
Assess
Soluble epoxide hydrolase in complex with LK864homo-2-mer229-547
E3N;MG;
Assess
Co-crystal of kurarinone with sEHhomo-2-mer230-548
J0U;
Assess
Soluble epoxide hydrolase in complex with TK90homo-2-mer229-547
TK9;
Assess
Soluble epoxide hydrolase in complex with 2-(4-fluorophenyl)-N-(4-phenoxybenzyl)ethanaminehomo-2-mer229-547
G3W;
Assess
Crystal structure of human bifunctional epoxide hydroxylase 2 complexed with A8homo-2-mer230-547
W9L;
Assess
Human soluble epoxide hydrolase in complex with a three substituted cyclopropane derivativehomo-2-mer230-545
S74;
Assess
X-ray structure of human soluble Epoxide Hydrolase C-terminal Domain (hsEH CTD)in complex with 15d-…homo-2-mer230-545
12×EDO;PTG;
Assess
Human soluble epoxide hydrolase in complex with a cyclopropyl urea derivativehomo-2-mer230-545
S94;
Assess
X-ray structure of apo human soluble Epoxide Hydrolase C-terminal Domain (hsEH CTD)homo-2-mer230-545
Assess
Human soluble epoxide hydrolase in complex with a synthetic inhibitorhomo-2-mer232-545
S38;
Assess
Crystal structure of human bifunctional epoxide hydroxylase 2 complexed with C9homo-2-mer234-547
W9M;
Assess
Human soluble epoxide hydrolase in complex with a synthetic inhibitorhomo-2-mer232-545
S82;
Assess
Soluble Epoxide Hydrolase complexed with a carboxamide inhibitorhomo-2-mer238-548
1LF;
Assess
Soluble epoxide hydrolase in complex with RK3monomer226-547
WJ5;EDO;
Assess
Soluble epoxide hydrolase in complex with Epoxykininmonomer228-547
12×EDO;XDZ;BR;
Assess
Soluble epoxide hydrolase in complex with RK4monomer228-547
W6O;EDO;
Assess
Crystal structure of human bifunctional epoxide hydroxylase 2 complexed with A4monomer234-547
7WI;
Assess
human sEH Phosphatase in complex with 3-4-3,4-dichlorophenyl-5-phenyl-1,3-oxazol-2-yl-benzoic-acidmonomer2-223
MG;8S9;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3wk6.1.Bhomo-2-mer0.892-547
MG;S0B;100.00
Assess

2 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 23wk6.1.Bhomo-2-mer0.871-494
S0B;100.00
Assess
Isoform 33wk6.1.Bhomo-2-mer0.871-481
S0B;100.00
Assess